WhaleCreep
Home › Funds › QVIDTVM Management LLC › Q4 2025

QVIDTVM Management LLC 13F holdings, Q4 2025

Holdings as of December 31, 2025 · filings on SEC EDGAR · latest filing →

QVIDTVM Management LLC disclosed 13 US equity positions worth $88.4m in its Q4 2025 13F filing. The largest position was BIO at 28.6% of the reported book, followed by SOLV and AMRZ. Against the Q3 2025 filing, it opened 5 new positions, added to 2 and reduced 6 among the top 13 holdings.

← Q3 2025 · Q1 2026 →

What did QVIDTVM Management LLC own in Q4 2025? Top 13 positions

#StockSectorWeightValueSharesΔ sharesvs Q3 2025
1 BIO BIO RAD LABS INC Healthcare 28.6%$25.3m83,483 -34% reduced
2 SOLV SOLVENTUM CORP Healthcare 26.1%$23.0m290,615 -41% reduced
3 AMRZ AMRIZE LTD Basic Materials 13.3%$11.7m216,556 – new
4 XRAY DENTSPLY SIRONA INC Healthcare 6.3%$5.5m485,409 -2% reduced
5 ZGN ERMENEGILDO ZEGNA N V Consumer Cyclical 5.5%$4.9m475,893 33892% added
6 COTY COTY INC Consumer Defensive 5.3%$4.7m1,515,888 -6% reduced
7 BRCC BRC INC 4.3%$3.8m3,400,681 2% added
8 EQIX EQUINIX INC Real Estate 3.8%$3.4m4,426 – new
9 NBIS NEBIUS GROUP N.V. Communication Services 3.3%$2.9m34,700 – new
10 ARE ALEXANDRIA REAL ESTATE EQ IN Real Estate 2.2%$2.0m40,000 – new
11 WAB WABTEC Industrials 0.8%$726.6k3,404 -65% reduced
12 LAB STANDARD BIOTOOLS INC Healthcare 0.3%$293.6k229,338 – new
13 RTO RENTOKIL INITIAL PLC 0.2%$202.7k6,879 -100% reduced

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.